Two orthopedic surgeons and an expert in pitching mechanics spoke to USA TODAY Sports about the lingering knee issues of Dodgers star Shohei Ohtani.

Driven by GLP-1 shortages and FDA compounding restrictions, a multi-billion-dollar gray market for injectable peptides ...

Unannounced tests in the middle of the night at the Tour have never been used before — but have been possible since 2016 ...

A dodgy doctor allegedly injected a Bronx woman before she died with a trendy supposed anti-aging molecule boosted by ...

After a young Bronx woman lost her life following an injection of NAD+, it begs the question what is really going on with the ...

When Sanofi won FDA approval in July 2026 for the first anticancer treatment administered with an on-body injector (OBI), the Enable Injections enFuse platform made it possible. The enFuse OBI secured ...

Minnesota's top prospect is proving he's ready, and the front office shouldn't wait for an injury to create an opportunity.

Nicotinamide adenine dinucleotide, or NAD+, is all the rage in the healthy aging space. Social media influencers tout NAD+ ...

Injuries have derailed the Kansas City Royals this season. And on Sunday, the club was dealt another serious blow. Royals ...

Shohei Ohtani won’t make his next scheduled start on the mound because of left knee irritation and isn’t expected back in the ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get the app that makes your AARP membership truly mobile! AARP ...